companydata.dkBoehringer Ingelheim Animal Health Denmark A/S: Financial statements 2020
CVR: 13526990
Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 622,610,000 and a net result of DKK 51,165,000 compared with DKK -21,145,000 the year before. That is an increase of 4.4% compared with the year before. The profit margin was 8.2%. Equity amounted to DKK 98,210,000. The solvency ratio was 34.7%. The company had 109 employees in the financial year.
- Revenue
- 622,610,000 kr.
- Gross Profit
- 147,650,000 kr.
- Profit/Loss
- 51,165,000 kr.
- Equity
- 98,210,000 kr.
- Total Assets
- 283,049,000 kr.
- Employees
- 109
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 622.6 mio. | 147.7 mio. | 51.2 mio. | 98.2 mio. | 109 |
| 2019 | 596.5 mio. | 100.4 mio. | -21.1 mio. | 46.7 mio. | 112 |
| 2018 | 573.7 mio. | 109.7 mio. | 7.6 mio. | 70.5 mio. | 114 |
| 2017 | 615 mio. | 923 mio. | 628.8 mio. | 687.5 mio. | 31 |
| 2016 | - | 39 mio. | 3.9 mio. | 27.6 mio. | 31 |
How creditworthy is Boehringer Ingelheim Animal Health Denmark A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 4, 2020, is registered as an owner of Boehringer Ingelheim Animal Health Denmark A/S with an ownership share of 100%.
Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2019. Revenue came to DKK 596,526,000, and the net result was DKK -21,145,000.
About Boehringer Ingelheim Animal Health Denmark A/S
Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.